1-3 of 3
Jude Canon
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Metabolic Reprograming of Exhausted Intratumoral CD8+ T-Cell Underlies Anti-Tumor Activity of Sumoylation Inhibitors in Large B Cell Lymphoma

Joseph Lownik, Larry Milshteyn, Anton Villamejor, Jude Canon, Akil Merchant
Journal: Blood
Blood (2023) 142 (Supplement 1): 3009.
https://doi.org/10.1182/blood-2023-188238
Published: 2023
Journal Articles

Pathway Analysis Provides Mechanistic Insights into Navtemadlin (KRT-232) Activity and Synergy with Decitabine in Acute Myeloid Leukemia Preclinical Models

Jin Wang, Venu Valmeekam, Kaijin Wu, Jiang F. Zhong, Andres Stucky, Xuelian (Lili) Chen, Alex Duong, Jude Canon, Cecile Marie Krejsa, Kevin R. Kelly
Journal: Blood
Blood (2021) 138 (Supplement 1): 2232.
https://doi.org/10.1182/blood-2021-145364
Published: 2021
Journal Articles

Inhibition of Mcl-1 Enhances the Efficacy of Tyrosine Kinase Inhibition in FLT3 Mutated AML and Synergizes with Venetoclax Targeting AML Stem Cells

Bing Z Carter, PhD, Wenjing Tao, Po Yee Mak, Qi Zhang, PhD, Xiangmeng Wang, Vinitha Mary Kuruvilla, MSc, Carli Stewart, Vivian Ruvolo, MS, Venkata Lokesh Battula, PhD, Marina Y Konopleva, MD PhD, Sean Caenepeel, Jude Canon, PhD, Paul Hughes, PK Morrow, Michael Andreeff, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1267.
https://doi.org/10.1182/blood-2019-125725
Published: 2019